MSA
PRTA icon

Marino Stram & Associates’s Prothena Corp PRTA Stock Holding History

Marino Stram & Associates’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1
Closed – – 438
2019
Q1 		$0 Buy
+1
New +$12 ﹤0.01% 658
2018
Q4 		– Sell
-1
Closed – – 654
2018
Q3 		$0 Hold
1
– – ﹤0.01% 503
2018
Q2 		$0 Hold
1
– – ﹤0.01% 517
2018
Q1 		$0 Hold
1
– – ﹤0.01% 486
2017
Q4 		$0 Buy
+1
New +$51 ﹤0.01% 472

Other funds holding PRTA

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Marino Stram & Associates's PRTA Position: Q2 2019 in Review

Marino Stram & Associates sold out of Prothena Corp (PRTA) in Q2 2019, closing a stake of 1 share.

Marino Stram & Associates first reported a position in PRTA in Q4 2017 and held it in 5 quarters. The position peaked at $0 in Q1 2019. 138 funds tracked by Wall St. Rank hold PRTA as of Q2 2019.

  • Marino Stram & Associates reported no remaining Prothena Corp position as of Q2 2019 after selling out during the quarter.
  • Marino Stram & Associates sold 1 Prothena Corp share in Q2 2019.
  • Marino Stram & Associates first reported a position in Prothena Corp in Q4 2017 and held it in 5 quarters.
  • Marino Stram & Associates's Prothena Corp position peaked at $0 in Q1 2019.
  • 138 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.